Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Brooks

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Medical Case Reports|November 11, 2022
Seizures, deep vein thrombosis, and pulmonary emboli in a severe case of May-Thurner syndrome: a case reportKevin D Seely, Heidi J Arreola, Loveleen K Paul, et al.
Experimental Brain Research|March 22, 2002
Pattern of cortical reorganization in amyotrophic lateral sclerosis: a functional magnetic resonance imaging studyCarsten Konrad, Henning Henningsen, Janbernd Bremer, et al.
IEEE Reviews in Biomedical Engineering|April 19, 2019
A Systematic Review of In Vitro and In Vivo Radio Frequency Exposure MethodsJared W Hansen, Ellen M Swartz, Jerika D Cleveland, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trialsVincent Meininger, Gilbert Bensimon, Walter R Bradley, et al.
The Journal of Biological Chemistry|December 6, 2001
S-adenosylmethionine decarboxylase from Leishmania donovani. Molecular, genetic, and biochemical characterization of null mutants and overproducersSigrid C Roberts, Jerry Scott, Judith E Gasteier, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 27, 2020
Nonclinical Safety Assessment of AMG 553, an Investigational Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Acute Myeloid LeukemiaChristine Karbowski, Rebecca Goldstein, Brendon Frank, et al.
Neurology. Clinical Practice|September 3, 2021
Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study DesignJames Berry, Benjamin Brooks, Angela Genge, et al.
Vaccine|June 3, 2019
Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvantsSita Awasthi, Lauren M Hook, Gokul Swaminathan, et al.
Lancet (London, England)|March 4, 2014
Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trialAnne-Marie Wills, Jane Hubbard, Eric A Macklin, et al.
The Lancet. Neurology|October 10, 2014
Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trialMerit E Cudkowicz, Sarah Titus, Marianne Kearney, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Medical Case Reports|November 11, 2022
Seizures, deep vein thrombosis, and pulmonary emboli in a severe case of May-Thurner syndrome: a case reportKevin D Seely, Heidi J Arreola, Loveleen K Paul, et al.
Experimental Brain Research|March 22, 2002
Pattern of cortical reorganization in amyotrophic lateral sclerosis: a functional magnetic resonance imaging studyCarsten Konrad, Henning Henningsen, Janbernd Bremer, et al.
IEEE Reviews in Biomedical Engineering|April 19, 2019
A Systematic Review of In Vitro and In Vivo Radio Frequency Exposure MethodsJared W Hansen, Ellen M Swartz, Jerika D Cleveland, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|June 19, 2004
Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trialsVincent Meininger, Gilbert Bensimon, Walter R Bradley, et al.
The Journal of Biological Chemistry|December 6, 2001
S-adenosylmethionine decarboxylase from Leishmania donovani. Molecular, genetic, and biochemical characterization of null mutants and overproducersSigrid C Roberts, Jerry Scott, Judith E Gasteier, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 27, 2020
Nonclinical Safety Assessment of AMG 553, an Investigational Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Acute Myeloid LeukemiaChristine Karbowski, Rebecca Goldstein, Brendon Frank, et al.
Neurology. Clinical Practice|September 3, 2021
Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study DesignJames Berry, Benjamin Brooks, Angela Genge, et al.
Vaccine|June 3, 2019
Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvantsSita Awasthi, Lauren M Hook, Gokul Swaminathan, et al.
Lancet (London, England)|March 4, 2014
Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trialAnne-Marie Wills, Jane Hubbard, Eric A Macklin, et al.
The Lancet. Neurology|October 10, 2014
Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trialMerit E Cudkowicz, Sarah Titus, Marianne Kearney, et al.
Pageof 3